Dermatophyte-Selective Imidazole-Thiosemicarbazides: Potent In Vitro Activity Against Trichophyton and Microsporum with No Anti-Candida Effect.

Int J Mol Sci · 2025 · PMC12525150 · PMID 41096704

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In addition, some dermatophyte infections require complex treatment regimens, and there is an increasing trend towards chronic infections, characterized by persistent or recurrent episodes lasting six months or longer despite treatment [ 35 , 36 , 37 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Dermatophyte-Selective Imidazole-Thiosemicarbazides: Potent In Vitro Activity Against &lt;i&gt;Trichophyton&lt;/i&gt; and &lt;i&gt;Microsporum&lt;/i&gt; with No Anti-&lt;i&gt;Candida&lt;/i&gt; Effect.

The sentences

Dermatophyte-Selective Imidazole-Thiosemicarbazides: Potent In Vitro Activity Against <i>Trichophyton</i> and <i>Microsporum</i> with No Anti-<i>Candida</i> Effect.